Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pulmonx Corp Director's Dealing 2022

Jun 3, 2022

34428_dirs_2022-06-03_d09675d4-8d1a-45eb-b776-b6beb038ab42.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2022-06-01

Reporting Person: Florin Daniel P (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-06-01 Common Stock A 5600 $0.00 Acquired 13132 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 15789 Indirect

Footnotes

F1: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 1, 2022, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made.

F2: The shares are directly held by Kelly A Florin Trust, for which the Reporting Person is a trustee.